EVERSANA's Vikram Anand explains how disconnected PV systems and manual safety processes can create commercial delays after ...
Ten PBMs will integrate TrumpRx cash pricing into RTBT displays, allowing prescribers and patients to compare cash-pay versus plan benefit costs at the point of prescribing. Clinician workflow remains ...
Cardinal Health's Michelle Britt discusses the operating costs, cash flow strain and reimbursement pressures facing ...
In this week's Pharma Pulse, Trump nominates Heidi Overton to lead the FDA, EVERSANA expands its AI-powered commercialization ...
Shawn Seamans, Chief Commercial Officer, CoverMyMeds | Authors | Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking ...
Trump is expected to pick White House aide Dr. Heidi Overton to lead the FDA, pending Senate confirmation, as the agency works to rebuild industry trust. Overton is among three finalists for the role, ...
Anamika Krishanpal, PhD, is a life sciences digital leader with over 15 years of experience operating at the intersection of biological domain science and digital engineering.
AI in PV can compress the interval between signal observation and documented action, preserving benefit–risk integrity and ...
EVERSANA's Vikram Anand breaks down FDA data on complete response letters, showing how gaps in pharmacovigilance and safety readiness, not manufacturing alone, drive costly delays in drug ...
EVERSANA's Vikram Anand breaks down FDA data on complete response letters, showing how gaps in pharmacovigilance and safety readiness, not manufacturing alone, drive costly delays in drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results